AbbVie Inc. (4AB.F)
Develops medicines for cancer, autoimmune diseases, and cosmetic treatments like Botox.
233.80-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+37.5%
The outlook
AbbVie is trading near its 52-week highs, well above both its 50- and 200-day moving averages. The stock carries a notably elevated trailing P/E of 129.9, and analyst coverage appears limited based on available data. Current price momentum sits at the upper end of its recent range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Market cap
$413.08B
52-wk high
234.40
52-wk low
163.80
50-day avg
206.26
200-day avg
192.66
Trailing P/E
129.9